Detalles de la búsqueda
1.
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
N Engl J Med
; 384(19): 1800-1809, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979488
2.
Biomarkers and clinical outcomes after tezepelumab cessation: extended follow-up from the 2-year DESTINATION study.
Ann Allergy Asthma Immunol
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697286
3.
Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study.
Allergol Int
; 72(1): 82-88, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977863
4.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
N Engl J Med
; 376(25): 2448-2458, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28530840
5.
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res
; 21(1): 279, 2020 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087119
6.
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res
; 21(1): 266, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050934
7.
Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study.
Pulm Ther
; 10(1): 53-67, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38064153
8.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Lancet Respir Med
; 11(5): 425-438, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702146
9.
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studies.
Immunotherapy
; 15(16): 1327-1340, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772607
Resultados
1 -
9
de 9
1
Próxima >
>>